Today's Top Health News Story

Bill Gates backs $30 million push for early Alzheimer's diagnostics

CHICAGO (Reuters) - Billionaire Bill Gates and Estée Lauder Cos chairman emeritus Leonard Lauder on Tuesday said they will award $30 million over three years to encourage development of new tests for early detection of Alzheimer's disease. Learn More


More Top Health Stories

China heart drug sold globally may have had impurity since 2012

LONDON (Reuters) - A common blood pressure and heart drug manufactured in bulk by a Chinese company and sold worldwide may have contained an impurity linked to cancer since 2012, European regulators said on Tuesday. More »


Judge rules for Trump administration in suit over family-planning program shift

(Reuters) - A federal judge ruled on Monday against birth control organizations that sought to block the Trump administration from shifting a federal family-planning grant program toward prioritizing groups that are faith-based and counsel abstinence. More »


Teen suicide risk may be lower with intense team-based therapy

(Reuters Health) - Adolescents who have harmed themselves or tried to commit suicide may be less likely to do it again when they participate in an intense therapy program focused on both individual and family treatment, a U.S. study suggests. More »


Roche touts new flu drug as Tamiflu suffers generics hit

ZURICH (Reuters) - Swiss drugmaker Roche's hopes of recapturing lost ground in the generics-flooded influenza market got a boost after a late-stage study showed its new medicine reduced symptoms in people at high risk of complications. More »


Mylan signs U.S. license deal on Humira with AbbVie

(Reuters) - AbbVie Inc said on Tuesday it signed a U.S. licensing deal with Mylan NV for its proposed biosimilar to AbbVie's blockbuster drug Humira, in a move that will give it more near-term control over the competition. More »


Evidence to support 'breakthrough' drugs often very limited: study

(Reuters Health) - The 46 medicines given approval through 2017 as part of the U.S. Food and Drug Administration's Breakthrough Therapy program have often been sent to patients without a large double-blind study, direct measurement of benefit, or comparison with a placebo or existing treatment, according to a new analysis by researchers at Yale University and the Yale School of Medicine. More »


Wide variation in follow-up care for women with low-risk breast cancer

(Reuters Health) - The kind of imaging U.S. women receive after treatment for non-metastatic breast cancer can vary widely, a new study finds. More »


Screen time linked to ADHD symptoms in teens

(Reuters Health) - Teens who spend lots of time surfing the web, playing games and chatting with friends on smartphones and tablets may be more likely to develop ADHD symptoms than youth who don’t, a U.S. study suggests. More »


J&J beats quarterly expectations on drug sales surge, shares jump

(Reuters) - Johnson & Johnson on Tuesday reported better-than-expected second quarter profit as sales of pharmaceuticals surged 20 percent despite a sharp decline in blockbuster arthritis drug Remicade, and its shares rose more than 4 percent. More »


News, Photo and Web Search